glimepiride Tablets 1 mg, 2 mg, 3 mg, 4 mg

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Manufacturer #20765
It is one of the first pharmaceutical manufacturing companies in the Arabian Peninsula and has been in operation since the 2000s. The company has manufacturing operations in more than 3 countries covering oral solids, liquids, dry powders for reconstitution, and sachets covering various therapeutics like cardiovascular, antidiabetics, anti-infective, cough & cold, musculoskeletal, gastrointestinal, dermatology, central nervous system.

Manufacturer usually replies in 17 days

GLIMEPIRIDE manufacturers

The manufacturers sell Glimepiride under the trade name Amaryl. This medication is primarily used in the treatment of type 2 Diabetes mellitus. However, it is less preferred in comparison to metformin. It is not recommended for type 1 diabetes as the pancreas cannot produce insulin. Hence, the working mechanism of the drug is not effective in the case of type 1 diabetes. This drug is categorized as a second-generation sulfonylurea. People with diabetes can develop life-threatening complications such as nerve problems, eye damage, kidney problems, stroke, and also heart disease. Taking medications and also making certain lifestyle changes can help in keeping blood sugar in check. This also improves the overall health of an individual. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking GLIMEPIRIDE: You should not use This medical remedy if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide.

How does GLIMEPIRIDE work?

Glimepiride is recommended in combination with exercise and diet. The common side effects noted with this drug are dizziness, nausea, and headache. Serious side effects include low blood sugar. It primarily functions by triggering the pancreas to release more insulin. Insulin is a chemical produced within the body that moves glucose into the cells from the bloodstream. Once the glucose gains entry into the cell, it is used as a fuel in metabolic activities. In the case of type 2 diabetes, the body doesn’t produce enough insulin. Also, the body is not capable of utilizing the insulin produced in the body in an effective manner. This causes an increase in the sugar levels in the bloodstream. This medical substance was patented in the year 1979. It was approved for medical use in 1995. The uses: Read the Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking Glimepiride. If you have any questions related to this medical remedy, ask your pharmacist or doctor. This medication is usually taken with the first main meal of the day. Recommendations followed by the doctor are to be followed. The dosage is dependent on the response to the treatment and also the medical condition. The medication has to be taken regularly and preferably at the same time each day. The doctor will start the course at a low dose to minimize the risk of side effects. The instructions followed by the doctor have to be followed carefully if the drug is being taken with another diabetes drug such as chlorpropamide. You should let your doctor know if your condition does not improve or if it worsens (your blood sugar is too high or too low). If you are looking to find manufacturers and suppliers of GLIMEPIRIDE, locate them quickly using Pipelinepharma's online marketplace. With this convenient B2B platform, you can order types of medications and quantities you require from companies that have passed our stringent vetting and quality control procedures.

The Wholesale Price of GLIMEPIRIDE?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost for GLIMEPIRIDE is around £7.00. The wholesale amount is around £1.66. Prices may vary on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of GLIMEPIRIDE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of GLIMEPIRIDE. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where GLIMEPIRIDE is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen GLIMEPIRIDE manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.